Related Articles
LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling
BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF‑κB/MGMT signaling pathway
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy